Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Abdalla Ibrahim, Leon G. Walsh, Mohamed Algaali, Zahir Satti, Thomas J. Kiernan & Bryan P. Yan. (2019) Insight into the perioperative management of direct oral anticoagulants: concerns and considerations. Expert Opinion on Pharmacotherapy 20:4, pages 465-472.
Read now
Read now
Francisco Marín, Manuel Anguita-Sánchez & Marcelo Sanmartín. (2017) Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation. Expert Opinion on Pharmacotherapy 18:1, pages 67-77.
Read now
Read now
Articles from other publishers (26)
Purva Patel, Monica Gaddis, Xuan Xu, Jim E. Riviere, Jessica Kawakami, Emma Meyer, Majid Jaberi-Douraki & Gerald J. Wyckoff. (2023) A retrospective study of adverse drug events in anticoagulant administration with relevance to COVID-19. Heliyon 9:3, pages e13763.
Crossref
Crossref
Olga V Kravchenko, Richard D Boyce, Ainhoa Gomez-Lumbreras, Paul T Kocis, Lorenzo Villa Zapata, Malinda Tan, Charles E Leonard, Kathleen M Andersen, Hemalkumar Mehta, G Caleb Alexander & Daniel C Malone. (2022) Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C). BMJ Open 12:12, pages e066846.
Crossref
Crossref
Robert Benamouzig, Maxime Guenoun, David Deutsch & Laurent Fauchier. (2021) Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants. Cardiovascular Drugs and Therapy 36:5, pages 973-989.
Crossref
Crossref
Qinhui Dong, Xiayin Zhu, Yafen Gao, Zhengrong Wang, Dexing Zheng & Jian Zhu. (2022) Analysis of the Preventive Action of Rivaroxaban against Lower Extremity Deep Venous Thrombosis in Patients after Laparoscopic Radical Gastrectomy. Computational and Mathematical Methods in Medicine 2022, pages 1-6.
Crossref
Crossref
Hind M. Alosaimi, Saeed Alqahtani, Bander Balkhi, Mishari Alqahtani, Faisal Alzamil, Abdulaziz Alhossan, Fatmah S. Alqahtany, Abdullah A. Alharbi, Nawaf Abdullah Alqahtani, Hanan Albackr, Ghada Elgohary & Farjah H. Algahtani. (2022) A retrospective study of real-world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia. PeerJ 10, pages e13974.
Crossref
Crossref
Ghazi I Arishi, Mohammed S Sheik & Abdulaziz Alhossan. (2022) Appropriateness of Prescribing Rivaroxaban at King Khalid University Hospital Riyadh. Cureus.
Crossref
Crossref
Kalaimani Elango, Awad Javaid, Banveet K. Khetarpal, Sathishkumar Ramalingam, Krishna Prasad Kolandaivel, Kulothungan Gunasekaran & Chowdhury Ahsan. (2021) The Effects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review. Cells 10:4, pages 773.
Crossref
Crossref
Oya Unsal Tan & Keriman Ozadali Sari. (2021)
Azolo[
d
]pyridazinones in medicinal chemistry
. Future Medicinal Chemistry 13:3, pages 287-311.
Crossref
Crossref
Muhammad Ajmal, Jacob Friedman, Qurat Ul Ain Riaz Sipra & Tom Lassar. (2021) Rivaroxaban: Expanded Role in Cardiovascular Disease Management—A Literature Review. Cardiovascular Therapeutics 2021, pages 1-9.
Crossref
Crossref
Kay A. Criswell. 2020. Biomarkers in Drug Discovery and Development. Biomarkers in Drug Discovery and Development
389
408
.
Gagan D. Flora & Manasa K. Nayak. (2019) A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes. Current Pharmaceutical Design 25:38, pages 4063-4084.
Crossref
Crossref
Nicolás E. Núñez-Navarro, Fabián M. Santana, Loreto P. Parra & Flavia C. Zacconi. (2019) Surfing the Blood Coagulation Cascade: Insight into the Vital Factor Xa. Current Medicinal Chemistry 26:17, pages 3175-3200.
Crossref
Crossref
V. М. Меretskyi & І. V. Меretska. (2019) Application of a new peroral anticoagulants in treatment and prophylaxis of thromboembolic complications. Klinicheskaia khirurgiia 86:6, pages 73-76.
Crossref
Crossref
(Major) Tejus A. (2019) A SIX YEAR DRUG UTILIZATION STUDY IN A TERTIARY HEALTHCARE SYSTEM: EMERGENCE OF NEWER ORAL ANTICOAGULANTS. Journal of Evidence Based Medicine and Healthcare 6:9, pages 676-679.
Crossref
Crossref
Nirav R. Patel, Dushyant V. Patel, Ashish M. KanhedSagar P. Patel, Kirti V. Patel, Daniel K. Afosah, Umesh R. Desai, Rajshekhar KarpoormathMange Ram Yadav. (2019) 2-Aminobenzamide-Based Factor Xa Inhibitors with Novel Mono- and Bi-Aryls as S4 Binding Elements. ChemistrySelect 4:3, pages 802-809.
Crossref
Crossref
Katie Lee, Samantha Cham & Sum Lam. (2018) Betrixaban. Cardiology in Review 26:6, pages 331-338.
Crossref
Crossref
Rami A. Al-Horani & Daniel K. Afosah. (2018) Recent advances in the discovery and development of factor XI/XIa inhibitors. Medicinal Research Reviews 38:6, pages 1974-2023.
Crossref
Crossref
Flavia C. Zacconi. 2018. Anticoagulant Drugs. Anticoagulant Drugs.
Joo Hee Kim, Kyung-Min Lim & Hye Sun Gwak. (2017) New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism. Biomolecules & Therapeutics 25:5, pages 461-470.
Crossref
Crossref
J. Zhou, J. Kochan, O. Yin, V. Warren, C. Zamora, G. Atiee, J. Pav, Y. Orihashi, V. Vashi & V. Dishy. (2017) A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects. Journal of Thrombosis and Haemostasis 15:5, pages 961-971.
Crossref
Crossref
Rebeca Pereira, André Lourenço, Luciana Terra, Paula Abreu, Valéria Laneuville Teixeira & Helena Castro. (2017) Marine Diterpenes: Molecular Modeling of Thrombin Inhibitors with Potential Biotechnological Application as an Antithrombotic. Marine Drugs 15:3, pages 79.
Crossref
Crossref
James Rankin, Menachem Nagar, Jonathan Crosby, Nojan Toomari, Richard Pietras & Uri M. Ben-Zur. (2016) Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report. Journal of Medical Case Reports 10:1.
Crossref
Crossref
Ng Zhang Jin & Subash C.B. Gopinath. (2016) Potential blood clotting factors and anticoagulants. Biomedicine & Pharmacotherapy 84, pages 356-365.
Crossref
Crossref
Brian K. Yorkgitis. (2016) Direct oral anticoagulants for venous thromboembolism treatment and prophylaxis. Journal of the American Academy of Physician Assistants 29:8, pages 24-29.
Crossref
Crossref
Tarik F. Ibrahim, Sean Maxwell & Omer Iqbal. 2016. Anticoagulation and Hemostasis in Neurosurgery. Anticoagulation and Hemostasis in Neurosurgery
33
46
.
Vikram C. Prabhu. 2016. Anticoagulation and Hemostasis in Neurosurgery. Anticoagulation and Hemostasis in Neurosurgery
327
342
.